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Abstract
Background: Heme oxygenase-1 (HO-1) catalizes heme degradation, and is considered one of
the most sensitive indicators of cellular stress. Previous work in human fibroblasts has shown that
HO-1 expression is induced by NO, and that transcriptional induction is only partially responsible;
instead, the HO-1 mRNA half-life is substantially increased in response to NO. The mechanism of
this stabilization remains unknown.
Results: In NIH3T3 murine fibroblasts, NO exposure increased the half-life of the HO-1 transcript
from ~1.6 h to 11 h, while treatments with CdCl2, NaAsO2 or H2O2 increased the half-life only up
to 5 h. Although poly(A) tail shortening can be rate-limiting in mRNA degradation, the HO-1
mRNA deadenylation rate in NO-treated cells was ~65% of that in untreated controls. In untreated
cells, HO-1 poly(A) removal proceeded until 30–50 nt remained, followed by rapid mRNA decay.
In NO-treated cells, HO-1 deadenylation stopped with the mRNA retaining poly(A) tails 30–50 nt
long. We hypothesize that NO treatment stops poly(A) tail shortening at the critical 30- to 50-nt
length. This is not a general mechanism for the post-transcriptional regulation of HO-1 mRNA.
Methyl methane sulfonate also stabilized HO-1 mRNA, but that was associated with an 8-fold
decrease in the deadenylation rate compared to that of untreated cells. Another HO-1 inducer,
CdCl2, caused a strong increase in the mRNA level without affecting the HO-1 mRNA half-life.
Conclusion: The regulation of HO-1 mRNA levels in response to cellular stress can be induced
by transcriptional and different post-transcriptional events that act independently, and vary
depending on the stress inducer. While NO appears to stabilize HO-1 mRNA by preventing the
final steps of deadenylation, methyl methane sulfonate achieves stabilization through the regulation
of earlier stages of deadenylation.
Background
Nitric oxide is a major messenger molecule with a broad
array of physiological functions, which include the ability
to promote cell survival during conditions of serum star-
vation and oxidative stress [1,2]. At the same time, NO is
a key effector of the cell-mediated immune response, act-
ing as a cytotoxic agent against invading pathogens [3], as
well as having the potential to cause DNA damage and cell
death in mammalian cells [4,5]. Such diverse and some-
times opposing roles can be better understood by consid-
ering the complex chemistry of NO. NO can react directly
with iron in heme and iron-sulfur proteins or, it can react
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with superoxide to form highly oxidizing peroxynitrite.
NO can also react with oxygen to generate higher nitrogen
oxides (N2O3, N2O4) in which NO is oxidized to the
nitrosonium ion (NO+), the NO redox form responsible
for its reactions with thiols [6,7].
In this way NO elicits both nitrosative and oxidative
stress, conditions that result in heme oxygenase-1 (HO-1)
up-regulation [8-10]. HO-1 catalyzes heme degradation,
and is induced by a variety of stress inducers, such as cad-
mium chloride (CdCl2), sodium arsenite (NaAsO2) and
hydrogen peroxide (H2O2), an effect that is consistent
with the role of HO-1 as a protective enzyme [11-13]. The
relevance of HO-1 induction in response to NO has
become apparent from studies with HO-1 knockout mice
and tissues, which show increased sensitivity to endotoxin
(a known inducer of NO synthase) [14]. Furthermore,
motor neurons respond to sub-lethal fluxes of NO by acti-
vating defense mechanisms that allow them to survive a
subsequent exposure to higher doses of NO. Under these
conditions, HO-1 is induced and its activity is required for
this adaptive resistance to NO [15-17].
HO-1 mRNA levels are also increased in response to NO
in human IMR90 lung fibroblasts, and transcriptional
induction is only partially responsible. Instead, the HO-1
mRNA half-life is substantially increased from ~2 h in
controls to >10 h in NO-treated cells [18,19]. Thus, NO
can regulate the HO-1 mRNA decay process and in this
way contributes to the up-regulation of HO-1 expression.
The decay of mRNA is a tightly controlled process depend-
ent on a core machinery for poly(A) tail shortening and 5'-
decapping, as well as a 5'→3' nuclease, and the exosome
responsible for 3'→5'decay [20,21]. In addition to these
factors, transcript-specific sequence elements and trans-
factors that bind them regulate the decay process [22]. In
general, poly(A) tail shortening (deadenylation) is the
rate-limiting step in this process, since it is required for
both 5'→3' and 3'→5' decay [23], and for several tran-
scripts decapping does not normally occur until the
poly(A) tail is sufficiently shortened [24].
Consistent with poly(A) tail shortening as a rate-limiting
step in mRNA decay, this step is targeted for regulation in
at least two other pathways: nonsense-mediated decay
(NMD) and decay of mRNA containing AU-rich sequence
elements (AREs). During deadenylation-dependent non-
sense-mediated decay, the presence of a premature termi-
nation codon results in an increased rate of poly(A) tail
shortening and subsequent decay of the aberrant tran-
scripts [25,26]. Shortening of the poly(A) tail is also rele-
vant for the decay of transcripts such as granulocyte/
monocyte colony stimulating factor, c-fos  and c-myc,
whose half-life is regulated by AREs [27]. These sequence
elements can act in cis to increase the rate of poly(A) tail
shortening and the overall decay of a stable β-globin tran-
script [28,29]. AREs mediate responses to cellular stresses
and pro-inflammatory stimuli, as evidenced by the regu-
lation of ARE-dependent deadenylation by p38 mitogen-
activated protein kinase [30]. ARE-binding proteins such
as AUF1 and HuR have been shown to regulate mRNA
half-life in response to genotoxic and oxidative stress
[31,32], and ARE-binding proteins that promote or
inhibit poly(A) tail shortening, such as tristetraprolin or
HuD, control the half-life of mRNA and are regulated by
growth factors, endotoxin, pro-inflammatory cytokines
and other extracellular stimuli [33-36]. Thus mRNA
poly(A) tail shortening can be a key step in an mRNA
decay pathway that is tightly regulated in response to
extracellular stimuli.
In this study, we have begun to dissect the mechanistic
pathway of HO-1 mRNA turnover and the effects of NO.
We examined the generality of HO-1 post-transcriptional
regulation in response to other sources of cellular stress.
We have also identified a novel regulatory mechanism in
which the initial rate of HO-1 mRNA poly(A) tail shorten-
ing in response to NO remains largely unaffected, with
stabilization achieved by preventing the final deadenyla-
tion steps or decapping. These results provide insights
into the mechanism of post-transcriptional regulation
and the role of deadenylation during cellular stress
responses.
Results
NO-mediated stabilization of HO-1 mRNA in NIH3T3 
cells
Previous studies in human IMR90 fibroblasts showed that
HO-1 mRNA is stabilized in response to NO [18,19].
However, because these primary cells senesce in culture
and posed experimental limitations, as an alternative we
tested mouse NIH3T3 fibroblasts for NO-induced stabili-
zation of the HO-1 message. To provide controlled NO
exposure in culture, we used the diazeniumdiolate NO
donors SPER/NO and DETA/NO, which release two mol-
ecules of NO per donor molecule at a steady and repro-
ducible rate [37]. We used SPER/NO for a 1-h NO
exposure (nominal half-life 45 min), or DETA/NO (nom-
inal half-life 20 h) for longer exposures to NO.
NIH3T3 cells were treated with 0.5 mM SPER/NO for 1 h,
after which transcription was blocked by adding 10 µg/ml
of AD. In untreated controls, HO-1 mRNA decayed with a
1.6 h half-life. Upon treatment with SPER/NO, HO-1
mRNA was stabilized with a half-life of 11 h (Fig. 1A, B).
To examine the specificity of this post-transcriptional reg-
ulation by NO, we measured in the same samples the half-
life of the unstable, stress-inducible transcript encoding
CL100 phosphatase [38]. Treatment with SPER/NO didBMC Molecular Biology 2007, 8:116 http://www.biomedcentral.com/1471-2199/8/116
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not stabilize CL100 mRNA (Fig. 1A), suggesting that the
effect on HO-1 mRNA is not due to a general inhibition of
NO on cellular mRNA turnover. Moreover, recent micro-
array results from this laboratory indicate that the stability
of the vast majority of mRNAs in NIH3T3 or IMR90 cells
is unaffected by NO (Rabinovic et al., manuscript in prep-
aration).
HO-1 mRNA induction experiments were also carried out
using a prolonged exposure to NO, in which NIH3T3 cells
were monitored in parallel for cell viability by trypan blue
exclusion. Increasing doses of DETA/NO resulted in
increased HO-1 mRNA stability, with the half-life ranging
from 1.6 h in controls, to 4.7 h, 7 h, and 11 h after DETA/
NO treatments of 0.2 mM, 0.5 mM and 2 mM, respec-
tively (Fig. 1C, D). There was also a negative correlation
between the DETA/NO level and cell proliferation during
Effect of NO exposure on HO-1 mRNA induction and stabilization Figure 1
Effect of NO exposure on HO-1 mRNA induction and stabilization. A. NIH3T3 cells were treated as controls or with 
an acute exposure to 0.5 mM SPER/NO for 1 h. AD was added to block transcription and total RNA was extracted at the indi-
cated times. HO-1 mRNA expression was monitored by northern blotting and normalized to GAPDH expression. The same 
blot was also probed for the expression of unstable CL100 mRNA.B. Quantification shows the fitted decay lines, calculated 
from three independent experiments. Data points show the mean and standard errors. * p < 0.05 as compared the HO-1 
mRNA remaining (% of initial) in untreated controls at the corresponding times. C. NIH3T3 cells were treated with the indi-
cated concentrations of DETA/NO for 6 h prior to the addition of AD, and the percentage of HO-1 mRNA remaining was 
quantified at the indicated time points.D. Quantification shows the fitted decay lines, calculated from two independent experi-
ments. Data points show the mean and standard errors. E. In parallel experiments, cells were trypsinized immediately after the 
treatment or at 8 h and 24 h after treatment, followed by trypan blue staining. To estimate viability, the values were normalized 
to 100% at time 0 h in untreated controls. Quantification in panel E shows the mean and standard error of three independent 
experiments, except for 0.5 mM dose, which corresponds to one experiment. ** p < 0.01, * p < 0.05 as compared to untreated 
controls at the corresponding times.
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24 h after the treatment (Fig. 1E). Although NO did not
seem to affect the viable cell number immediately after
the treatment and for up to 10 h, the interval during
which mRNA stability was assessed, by 24 h post-exposure
an effect on cell proliferation was apparent. The untreated
cell population doubled in 24 h, as was true for the cells
exposed to 0.05 mM DETA/NO. However, at higher
DETA/NO levels, cell proliferation was prevented (Fig.
1E). Note that there was no loss in cell viability immedi-
ately after NO treatment with up to 1 mM DETA/NO, and
only a small decrease in viability in cells treated with 2
mM DETA/NO (Fig. 1E), conditions under which the HO-
1 mRNA was strongly stabilized (Fig. 1C, D). These effects
of DETA/NO on HO-1 mRNA stabilization and cell prolif-
eration, were similarly produced by treatment with S-
nitroso-L-glutathione (Additional File 1). Thus NIH3T3
cells are a suitable model to further characterize the mech-
anism of HO-1 mRNA stabilization by NO.
Effect of CdCl2, NaAsO2 and H2O2 on HO-1 mRNA 
induction and stabilization
To determine whether the post-transcriptional regulation
of HO-1 mRNA was specific to NO or part of a general
stress response, and to inform the chemistry of this sign-
aling pathway, we tested several compounds chemically
unrelated to NO for their effect on HO-1 mRNA stability.
The molecular targets of these compounds overlap par-
tially with those of NO. In particular, the reactions of NO
with thiols to form nitrosothiols [39], and the eventual
depletion of intracellular glutathione [40,41], prompted
us to investigate the oxidant H2O2, and the thiol-reactive
compounds CdCl2 and NaAsO2, which can alter the redox
equilibrium [42,43].
The contribution of post-transcriptional events in regulat-
ing expression of the HO-1 mRNA was determined for dif-
ferent concentrations of CdCl2, NaAsO2 and H2O2 in a 6-
h exposure. All three agents, at concentrations that
induced HO-1 mRNA to steady-state levels comparable to
those produced by NO (data not shown), had an effect on
HO-1 mRNA stability, but in all cases less than the effect
observed for NO treatment (Fig. 2A, B). Under our condi-
tions, CdCl2, NaAsO2 and H2O2increased the half-life of
HO-1 mRNA to 5–6 h, while a treatment with 2 mM
DETA/NO resulted in an HO-1 mRNA half-life of 11 h
(Fig. 2A, B). Thus, other sources of cellular stress can affect
HO-1 mRNA stability. At the concentrations used, CdCl2,
NaAsO2  and H2O2  did not prevent cell proliferation
throughout a 24-h time course after the treatments, in
contrast to the decreased cell proliferation and viability
observed in response to NO. (Fig. 2C).
Effect of methyl methane sulfonate on HO-1 mRNA 
stability
To address the possibility that inhibition of cell prolifera-
tion stabilizes HO-1 mRNA, we treated NIH3T3 cells with
methyl methane sulfonate (MMS), a compound that
alkylates DNA and other cellular targets in a non-oxida-
HO-1 mRNA induction and stabilization in response to  CdCl2, NaAsO2 or H2O2 Figure 2
HO-1 mRNA induction and stabilization in response 
to CdCl2, NaAsO2 or H2O2. A. Cells were treated with 2 
mM DETA/NO, 25 µM CdCl2, 10 µM NaAsO2, 250 µM 
H2O2 or 2 mM DETA/NO for 6 h, followed by the addition 
of AD to monitor HO-1 decay over time. HO-1 mRNA was 
detected by northern blotting and normalized to GAPDH 
loading controls.B. For each treatment in panel A, the fitted 
decay lines were calculated using data from three independ-
ent experiments and plotted. Data points show the mean and 
standard errors. * p < 0.05 as compared to HO-1 mRNA 
expression in control samples at the corresponding times. C. 
The same doses as for panel A were used to determine the 
effect of these treatments on NIH3T3 cell number, 
expressed as the percentage of trypan blue-negative cells 
compared to 100% at time 0 h for untreated controls. Quan-
tification shows the mean and standard error of three inde-
pendent experiments. * p < 0.05 as compared to untreated 
controls at the corresponding times.
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tive fashion. Treatment with MMS affected both cell via-
bility and HO-1 mRNA stability (Fig. 3). At 0.5 mM MMS,
HO-1 mRNA was partly stabilized, and treatment with 1
mM MMS resulted in an HO-1 mRNA half-life of >12 h,
comparable to that attained with NO-treatment. How-
ever, the stabilizing MMS treatments were accompanied
by strong inhibition of cell proliferation and reduced via-
bility 24 h after the exposure, and in the 2 mM treatment,
decreased GAPDH mRNA levels (Fig. 3C).
HO-1 mRNA stabilization is not due to the use of an 
alternative transcriptional start site
For most mRNAs, decay begins with shortening of the 3'
poly(A) tail followed by 5' decapping and then rapid
digestion of the body of the message. In some cases, sta-
bility is regulated through the use of alternative polyade-
nylation sites [44,45], or through alternative
transcriptional start sites to give different 5' untranslated
regions (UTRs) [46,47]. We have closely examined the
short 93-nt 3'UTR of HO-1 for known polyadenylation
motifs [45], and have only found a single polyadenylation
motif, which suggests that HO-1 mRNA is not regulated
through an alternative polyadenylation site in this region.
Additional potential polyadenylation motifs also seem to
be absent from the murine HO-1 gene. We therefore per-
formed primer extension assays to determine the tran-
scriptional start site of HO-1 mRNA in control and NO-
treated cells (Additional File 2). The HO-1 transcripts
from both the control NIH3T3 and the NO-treated cells
yielded main products of indistinguishable mobility,
which corresponded to the reported mouse HO-1 tran-
scriptional start site [48]. Primer extension products from
cells treated with CdCl2 and MMS were also similar to
products from untreated cells, and again corresponded to
the reported transcriptional start site (data not shown).
Thus, HO-1 mRNA induction by these agents was not
associated with the use of an alternative transcriptional
start site.
NO does not prevent deadenylation but affects the 
deadenylation rate
Shortening of the 3' poly(A) tail (deadenylation) is often
rate-limiting in mRNA decay, and we therefore developed
a deadenylation assay specific for endogenous HO-1
mRNA. DNA oligonucleotides were used to target RNase
H cleavage prior to separation of the fragments by gel elec-
trophoresis and detection by northern blotting [28]. The
length of the poly(A) tail in HO-1 mRNA was estimated
by comparison against size markers, including a fully
deadenylated HO-1 fragment generated in vitro.
NIH3T3 cells were treated with 0.5 mM SPER/NO for 1 h,
followed by the addition of AD and sampling at various
times thereafter. Part of each sample was used without fur-
ther modification to assess the half-life of HO-1 mRNA
Effect of increasing concentrations of MMS on HO-1 mRNA  turnover and NIH3T3 cell proliferation Figure 3
Effect of increasing concentrations of MMS on HO-1 
mRNA turnover and NIH3T3 cell proliferation. A. 
Cells were treated with the indicated concentrations of MMS 
for 6 h, followed by the addition of AD and RNA extraction 
at the indicated time points. HO-1 mRNA was detected by 
northern blotting and normalized to GAPDH loading con-
trols.B. For each concentration in panel A, the fitted decay 
lines were calculated using data from three independent 
experiments and plotted. Data points show the mean and 
standard errors. C. In parallel experiments viable cells 
(trypan blue-negative) were counted immediately after the 
treatment (time 0 h) and at 8 h and 24 h after treatment. The 
percentage of viable cells shown is relative to 100% cell 
number at time 0 h in untreated controls. The graph shows 
the mean and standard error of three independent experi-
ments. * p < 0.05 as compared to untreated controls at the 
corresponding times.
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(Fig. 4C), and the rest of the sample was used in a deade-
nylation assay. Upon oligo-directed cleavage, as seen in
Fig. 4A, two distinct HO-1 mRNA populations were
detected in the samples from NO-treated cells: a steady-
state population that had undergone different extents of
poly(A) tail shortening, and newly transcribed HO-1
mRNA that had the longest poly(A) tails of ~250-nt (Fig.
4A, compare control and NO-treated samples at 0 h). The
latter mRNA population resembles the product expected
from a transcriptional pulse [27], consistent with HO-1
induction by NO including both transcriptional (during
the NO exposure) and post-transcriptional components
[19]. In this regard, it is important to note that because
our experiments have the advantage of analyzing the
endogenous HO-1 mRNA rather than an inducible tran-
script, the starting point of our experiments represents the
steady state population of mRNAs that have undergone
different extents of decay. Thus, evaluating the average
intensities in our deadenylation assays would neglect to
consider the actual rate of shortening of the longer
poly(A) tails. Therefore, we marked the position below
which 95–98% of the signal remained, and considered
this upper 2–5% boundary to correspond to the mRNAs
with the longest poly(A) tails, and the only part of the sig-
nal where we could accurately monitor poly(A) tail short-
ening (see dotted lines in each lane of Fig. 4A). This
analysis showed that poly(A) shortening of HO-1 mRNA
occurred in both the control and the NO-treated samples
(Fig. 4B). From these results, we estimated that, during the
first 8 h of the time course, the initial rate of deadenyla-
tion was about 1.5-fold slower in the NO-treated samples
(1.3-nt per min) than in the controls (1.9-nt per min).
Fully deadenylated HO-1 mRNA was not detected in
either the control or the NO-treated case. The smallest
detectable fragments corresponded to a poly(A) tail of
30–50 residues, which suggests that rapid decay occurs if
the poly(A) tail is shortened beyond this point. In NO-
treated cells, poly(A) tail shortening up to 30–50 nt
occurred in spite of the increased HO-1 mRNA half-life.
Importantly, in contrast to controls, these shorter decay
intermediates were readily detected at later time points in
the NO-treated samples (Fig. 4A, compare control and
NO-treated samples at 8 h and 12 h).
MMS treatment stabilizes HO-1 mRNA by affecting the 
deadenylation rate
To determine whether altered deadenylation of HO-1
mRNA is a general mechanism for its post-transcriptional
regulation, we analyzed this process in MMS-treated cells.
We treated NIH3T3 cells with 1 mM MMS for 6 h, and fol-
lowed this treatment with the addition of AD to the
medium to monitor the deadenylation and decay of HO-
1 mRNA through a 12-h time course. HO-1 mRNA expres-
sion was induced 10-fold by the MMS treatment and its
mRNA was stabilized, with the half-life increased from 2
h in control samples to >12 h in MMS-treated cells (Fig.
5). In control and MMS-treated samples both polyade-
nylated intermediates and partially deadenylated HO-1
mRNA were detected immediately after the addition of
AD (Fig. 5A). In control samples, HO-1 mRNA underwent
significant poly(A) tail shortening and decay by 4 h (Fig.
5A, C), whereas treatment with MMS significantly
decreased the HO-1 mRNA deadenylation rate. Although
during the first 2 h of the AD time course the rate was only
1.5-fold slower than in controls, the effect of MMS on the
HO-1 mRNA deadenylation rate was more pronounced
after 2 h: after initial shortening to a poly(A) size of ~200-
Effect of NO on HO-1 mRNA deadenylation and stability Figure 4
Effect of NO on HO-1 mRNA deadenylation and sta-
bility. A. NIH3T3 cells were treated as controls or with 
NO, and total RNA samples were assayed for HO-1 mRNA 
deadenylation. To compensate for the differences in the 
starting amount of HO-1 mRNA between control and NO-
treated cells where HO-1 mRNA is induced immediately 
after the SPER/NO treatment, 35 µg and 6 µg of total mRNA 
were used in a cleavage reaction from untreated controls 
and NO-treated samples, respectively. Residual full-length 
HO-1 mRNA and the 3' end fragment carrying the poly(A) 
tail are indicated. FD represents HO-1 mRNA that was fully 
deadenylated in vitro. B. The upper boundary of the mRNA 
was set at a position below which 95–97% of the total HO-1 
mRNA band area was included. The size of the poly(A) tail 
was estimated by comparing the migration of the upper 
bound to that of the FD (522-nt) and 623-nt size markers. C. 
A fraction of the samples was used without further modifica-
tion to assess the half-life of HO-1 mRNA by northern blot-
ting. Quantification in panels B and C shows the fitted decay 
lines calculated from two independent experiments. Data 
points show the mean and standard errors.
A.
B. C.
0
100
200
300
02468 1 0 1 2
Control
NO
Time after AD (h)
S
i
z
e
 
o
f
 
 
p
o
l
y
(
A
)
 
t
a
i
l
 
(
n
t
)
0  1   2  4   8 12   0  1   2   4  8 12 FD    M
Control SpermineNO
623 nt
522 nt
3’ fragment
Full length
Time AD (h)
Ethidium
Bromide
1
10
100
02468
H
O
-
1
 
m
R
N
A
 
r
e
m
a
i
n
i
n
g
(
%
 
o
f
 
i
n
i
t
i
a
l
)
Time after AD (h)
Control
NOBMC Molecular Biology 2007, 8:116 http://www.biomedcentral.com/1471-2199/8/116
Page 7 of 14
(page number not for citation purposes)
nt, the deadenylation rate in the MMS-treated samples
was ~8-fold slower than in controls.
Transcriptional up-regulation does not result in HO-1 
mRNA stabilization
Previous experiments in human IMR90 fibroblasts sug-
gested that transcription inhibition may partially affect
the stabilization of HO-1 mRNA by NO, decreasing the
mRNA half-life from 10 h to 6 h [18]. Since transcription
is tightly coupled to mRNA splicing, polyadenylation,
capping, export, and stability [49,50], we decided to
address the effect of transcription on HO-1 mRNA stabil-
ity.
To this end, NIH3T3 cells were treated with CdCl2 under
conditions that resulted in a 4-fold HO-1 mRNA induc-
tion, similar to that of NO. The CdCl2 treatment increased
the HO-1 mRNA half-life only modestly to ~4 h (Fig. 2B
and 6C). As seen in Fig. 6A, HO-1 mRNA underwent
deadenylation in CdCl2-treated cells with an initial rate
similar to that estimated for the untreated controls (1.7-nt
per min in CdCl2 samples vs. 1.9-nt per min in controls).
These results suggest that post-transcriptional events con-
tribute only marginally to the HO-1mRNA up-regulation
in response to CdCl2.
Discussion
In this study we established that NIH3T3 mouse fibrob-
lasts showed an increase in HO-1 mRNA steady-state lev-
els in response to acute exposure to NO released from
SPER/NO. This increase also correlated with a significant
increase in the HO-1 mRNA half-life, which was also
observed in response to a prolonged NO exposure using a
slow-releasing diazeniumdiolate, DETA/NO or S-nitro-
soglutathione. These observations are in agreement with
published reports showing strong HO-1 mRNA induction
in response to NO in other cell types [8-10,16,17] and
with its induction and stabilization in human IMR90
Effect of CdCl2 on HO-1 mRNA deadenylation and stability Figure 6
Effect of CdCl2 on HO-1 mRNA deadenylation and 
stability. A. NIH3T3 cells were treated as controls or with 
2.5 µM CdCl2 for 6 h, and total RNA was assayed for HO-1 
mRNA deadenylation. Residual full-length mRNA and the 3' 
end fragment carrying the poly(A) tail are indicated. FD rep-
resents the fully deadenylated 3' fragment of HO-1 mRNA. 
B. The size of the poly(A) tail was estimated as for Fig. 5. C. 
A fraction of the samples was used without further modifica-
tion to assess the half-life of HO-1 mRNA. Quantification in 
panels B and C shows the fitted decay lines calculated from 
two independent experiments. Data points show the mean 
and standard errors.
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Effect of MMS on HO-1 mRNA deadenylation and stability Figure 5
Effect of MMS on HO-1 mRNA deadenylation and 
stability. A. NIH3T3 cells were treated as controls or with 
1 mM MMS for 6 h, and total RNA samples (20 µg and 7.5 µg, 
respectively) were assayed for HO-1 mRNA deadenylation. 
Residual full-length mRNA and the 3' end fragment carrying 
the poly(A) tail are indicated. FD represents a fully deade-
nylated 3' fragment of HO-1 mRNA. B. The size of the 
poly(A) tail was estimated as for Fig. 5. C. A fraction of these 
samples was used without further modification to assess the 
half-life of HO-1 mRNA. Quantification in panels B and C 
shows the fitted decay lines calculated from two independent 
experiments. Data points show the mean and standard 
errors.
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fibroblasts [18,19] and rat aortic smooth muscle cells in
response to various sources of NO [10]. On the other
hand, we have not been able to demonstrate NO-medi-
ated stabilization of the HO-1 message in HeLa or HepG2
cells (unpublished data), which suggests that the mecha-
nism may be limited to certain cell types.
Treatment with NO, at concentrations that increased HO-
1 mRNA stability, prevented cell proliferation during the
24 h after exposure. This observation is in agreement with
the ability of NO to cause cell cycle arrest [51,52]. It also
parallels reports where exposure to DETA/NO prevented
NIH3T3 cell proliferation in a p53-dependent manner,
causing the induction of several growth-arrest genes: p21,
GADD45 and Bax [53]. The induction and stabilization of
HO-1 mRNA under stress conditions that compromise
cell growth is consistent with its proposed role in mediat-
ing cell survival during nitrosative and oxidative stress
[14,16,17].
Also in agreement with this role is the induction and sta-
bilization of HO-1 in response to CdCl2, NaAsO2 and
H2O2. These agents, although chemically unrelated to
NO, have overlapping effects on cellular physiology
through the depletion of cellular glutathione, which shifts
the redox equilibrium in the cell [42,43], and can also
affect the cell cycle and viability [54-58]. It is important to
note that, in our study, we used exposures to CdCl2,
NaAsO2 and H2O2 similar to those previously reported to
induce HO-1expression [11-13]. These concentrations
were lower than those reported to affect the cell cycle and,
in agreement with this, failed to block cell proliferation
during 24 h after the exposure. It is then possible that
higher concentrations of these agents are required to
achieve the degree of HO-1 mRNA stabilization seen with
NO. In the case of CdCl2, concentrations of 75 µM and
higher were needed to stabilize HO-1 mRNA, but under
these conditions, stability was accompanied by massive
ribosomal and messenger RNA degradation (data not
shown). The increase in the HO-1 mRNA half-life
observed in response to the non-NO agents, at concentra-
tions that resulted in a similar HO-1 mRNA induction to
that elicited by NO, shows that other sources of cellular
stress may regulate HO-1 gene expression post-transcrip-
tionally, and that HO-1 mRNA stabilization is not exclu-
sive to NO. Overall, however, the most dramatic increase
in HO-1 mRNA half-life was consistently observed with
NO. Therefore it is possible that, in addition to thiol-
dependent reactions and oxidative stress, other NO-spe-
cific reactions might mediate the post-transcriptional reg-
ulation of HO-1.
Because NO treatments that resulted in HO-1 mRNA sta-
bilization were also associated with a decrease in cell pro-
liferation, we assessed HO-1 mRNA stability in response
to MMS, a cytotoxic alkylating agent. In agreement with
published reports [59,60], increasing concentrations of
MMS caused a decrease in the number of viable cells over
time. Interestingly, although chemically unrelated to NO,
MMS exerted significant stabilization of the HO-1 mRNA,
expanding the list of known HO-1 inducers. In this
respect it is noteworthy that MMS can activate mitogen-
activated protein kinase (MAPK) pathways in a DNA dam-
age-independent manner, modulated by the intracellular
level of glutathione [61], perhaps through the ability of
MMS to alkylate sulfhydryl groups. Therefore, as HO-1
mRNA induction has been reported to depend on the acti-
vation of MAPK pathways in some cell types
[11,12,57,62], and HO-1 up-regulation is modulated by
the intracellular glutathione status (reviewed in [63]), it is
possible that MMS and NO regulate HO-1mRNA induc-
tion and stabilization through overlapping mechanisms.
To begin to address the mechanism of post-transcrip-
tional regulation of HO-1 in NIH3T3 cells, and because
no evidence for alternative polyadenylation sites within
the HO-1 gene was found, we tested whether HO-1 induc-
tion by NO is accompanied by the use of an alternative
transcriptional start site, which could in turn result in dif-
ferences in the 5' untranslated region of HO-1 mRNA and
affect its stability. Such an effect has been reported for
unstable c-myc mRNA and IGFII mRNA, which can be
transcribed from different promoters, and whose stability
is regulated through the use of alternative transcriptional
start sites [46,47]. Unlike these cases, the HO-1 transcrip-
tional start site was not affected by any of the stabilizing
treatments (NO exposure or MMS), consistent with other
data showing that HO-1 mRNA post-transcriptional regu-
lation by NO can occur independently of transcription
[18].
We also monitored the effect of NO and other stress
inducers on HO-1 mRNA deadenylation, since deadenyla-
tion has been described as the rate-limiting step in mRNA
decay [23-27]. In stabilizing HO-1 mRNA, NO had only a
small effect on the initial rate of poly(A) tail shortening,
acting instead to prevent the complete deadenylation of
HO-1 mRNA past a 30–50-nt critical poly(A) tail length.
A minimum poly(A) tail past which degradation occurs
has been previously described for globin and histone
mRNAs injected in Xenopus laevis extracts (reviewed in
[64]), although such a critical length is not applicable to
all mRNAs, because in this system the half-life of inter-
feron mRNAs was independent of the length of their
poly(A) tail [65]. In this regard, it is interesting to note
that, a significant amount of the HO-1 mRNA from NO-
treated samples remained sufficiently polyadenylated to
be retained on oligo(dT) Sepharose 8 h after treatment
(Additional File 3: Recovery of polyadenylated (A>30) HO-
1 mRNA from NO-treated cells). An alternative possibilityBMC Molecular Biology 2007, 8:116 http://www.biomedcentral.com/1471-2199/8/116
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is that NO acts to block decapping, or the activity of endo-
nucleases that might be activated when the poly(A) tail is
significantly shortened. This mechanism of stabilization
of HO-1 mRNA is in contrast to the mRNA post-transcrip-
tional regulation described for NMD and ARE-mediated
decay, where the half-life of a transcript containing a pre-
mature termination codon or an ARE is regulated through
changes in its deadenylation rate [25-27]. In our experi-
ments, we estimated that the >5-fold increase in the HO-
1 half-life that occurs in response to NO is unlikely to be
the result of differences in the HO-1 deadenylation rate,
because the poly(A) tail of HO-1 mRNA in NO-treated
cells was shortened with a rate that was only 1.5-fold
slower than that of control cells.
Our experiments with MMS show that a different form of
cellular stress can also stabilize HO-1, but by a different
mechanism that involves a dramatic change in the rate of
shortening the poly(A) tail from ~200-nt down. We have
also demonstrated that, in spite of strong transcriptional
induction of HO-1 in response to CdCl2, this agent did
not strongly affect the rate of poly(A) tail shortening and
had only a small effect on the HO-1 mRNA half-life. As
CdCl2-induced transcription did not change the start site,
this experiment further supports the conclusion that stabi-
lization occurs independently of HO-1 mRNA transcrip-
tion, and excludes the possibility that detection of
oligoadenylated HO-1 mRNA through the time course is
merely a by-product of elevated HO-1 mRNA levels prior
to the addition of AD in the treated samples.
Here we have characterized a mechanism for the post-
transcriptional regulation of HO-1 mRNA where stabiliza-
tion can occur essentially independently of the initial rate
of poly(A) tail shortening, by preventing the final steps of
deadenylation or a subsequent step in decay. Such regula-
tion has been reported for the stabilization of transcripts
in an in vitro decay assay, where purified ELAV proteins
did not affect deadenylation of ARE-containing mRNA,
but prevented the decay of deadenylated transcripts [66].
Moreover, the differential regulation for the initial rate of
poly(A) tail shortening and the terminal deadenylation
rate has been described for the GAP-43 mRNA by HuD, a
neuronal ARE-binding protein that can prevent poly(A)
tail shortening from transcripts containing a long poly(A)
tail (A150) [34,36,67]. HuD appears to have no effect on
the deadenylation and decay rates of GAP-43 transcripts
with short tails (A30), perhaps because of lower binding
affinity for these transcripts [34] than for transcripts with
longer poly(A) tails [34]. In a similar way, an NO-induced
stabilizing factor that would preferentially bind certain
mRNAs with short poly(A) tails (A30–50) would affect only
the terminal steps of HO-1 mRNA deadenylation. Indeed,
some recent experiments demonstrate NO-inducible
binding to the 3' UTR of HO-1 mRNA by cellular proteins
(A. Rabinovic et al., manuscript in preparation).
Differential regulation of the rate of poly(A) tail shorten-
ing and terminal deadenylation could also be achieved
though the differential regulation of cellular deadeny-
lases. To date, the activity of PARN, a major cellular dead-
enylase, has been well characterized in HeLa S100 extracts
[68]. In addition to PARN, two yeast deadenylase activi-
ties conserved in higher eukaryotes have been character-
ized: Ccr4/Caf1 and Pan2/Pan3 [69]. While both activities
are required for normal deadenylation in yeast, Pan2/
Pan3 stops at the last 20–26-nt, perhaps due to its require-
ment for poly(A) binding protein (Pab1p) as a cofactor,
and only the Ccr4/Caf1 complex can process the last
phase of deadenylation [23,70]. The Pan2/Pan3 complex
has been identified in HeLa cells, where its activity is also
stimulated by polyadenylate-binding protein (PABP)
[71]. Thus, regulating the activity of one or the other dead-
enylase would have distinct effects on the rate of poly(A)
shortening and terminal deadenylation, and such a mech-
anism could account for the differential effects of MMS
and NO on the rate of HO-1 mRNA poly(A) tail shorten-
ing and terminal deadenylation.
Conclusion
In this work we have demonstrated nitric oxide-induced
stabilization of HO-1 mRNA in NIH3T3 murine fibrob-
lasts. HO-1 mRNA stabilization in NIH3T3 cells can also
occur less dramatically in response to H2O2, CdCl2 and
NaAsO2. The stabilizing effect of NO on HO-1 did not
appear to be due to a generalized inhibition of cellular
mRNA turnover, nor to the activation of an alternative
transcriptional start site.
HO-1 mRNA was deadenylated in both control and NO-
treated cells, and only slightly more slowly in the latter. In
neither case were fully deadenylated transcripts detected,
which suggests that poly(A) shortening proceeds to a crit-
ical point, beyond which rapid decay of the entire mRNA
ensues. NO appears to prevent the final shortening step,
or possibly the subsequent decapping reaction. Such a sta-
bilization mechanism is distinct from the effect on HO-1
mRNA stability of MMS, which significantly decreases the
poly(A) shortening rate. A third agent, CdCl2, induces
HO-1 mRNA transcriptionally without a significant effect
on deadenylation, which is therefore mechanistically
unlinked to transcription for HO-1.
Methods
Reagents
Nitric oxide donors spermine diazeniumdiolate (SPER/
NO) and DETA NONOate (DETA/NO) were purchased
from Alexis Corporation (San Diego, CA). Methyl meth-
ane sulfonate (MMS), hydrogen peroxide, cadmium chlo-BMC Molecular Biology 2007, 8:116 http://www.biomedcentral.com/1471-2199/8/116
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ride and actinomycinD (AD) were purchased from the
Sigma Chemical Co. (St. Louis, MO). RNase H enzyme,
ammonium acetate, glycogen, and RNase inhibitors RNA-
sin and SuperaseIN were purchased from Ambion (Aus-
tin, TX). T4-polynucleotide kinase was purchased from
New England Biolabs (Beverly, MA).
Cell culture and treatments
Mouse NIH3T3 fibroblasts were grown in Dulbecco's
Modified Eagle Medium supplemented with 10% (v/v)
bovine calf serum, 50 international units/ml penicillin,
50 µg/ml streptomycin and 40 µM glutamine.
To determine the stability of HO-1 mRNA, NIH3T3
fibroblasts were seeded in T-25 flasks at a density of 2.5 ×
105 cells per flask and grown for 2 d before the experi-
ment.
Cells were treated with the NONOates, or either CdCl2,
NaAsO2, H2O2 or methyl methane sulfonate (MMS) at the
concentrations and times indicated in the results. Treat-
ment was stopped by replacing the medium with condi-
tioned medium supplemented with the transcriptional
inhibitor AD to a final concentration of 10 µg/ml. Cells
were frozen in liquid nitrogen at the indicated times
throughout the time course and stored at -80°C until RNA
extraction. Conditioned medium is medium in which
cells have been cultured for 2 d, and is used throughout
these experiments to prevent the transcriptional induction
of HO-1 mRNA that occurs in response to fresh medium
[19].
For the primer extension assays and each time point in the
deadenylation assays, 1 × 106 cells were seeded in T-75 tis-
sue culture flasks, and grown for 2 d before the experi-
ment. Cells were treated with 0.5 mM SPER/NO for 1 h
before the addition of AD, as described above. MMS treat-
ments were done by preparing a 120 mM stock and add-
ing it to the cell medium to reach a 1 mM final
concentration. CdCl2 treatments were done by preparing
a 5 mM stock solution and adding enough to the cell
media to reach a 2.5 µM final concentration. Both the
MMS and the CdCl2 treatments were carried out for 6 h
before replacing the media with conditioned medium and
AD.
Cell survival
Cells were seeded at a density of 1.3 × 105 cells per well in
a 6-well culture plate with 3 ml of media, and incubated
for 2 d before treatment with the indicated agents as
described above. After 6 h, treatment medium was
replaced with 3 ml of conditioned medium, and the cells
were further incubated at 37°C under 5% CO for the indi-
cated times before harvesting for the survival determina-
tion. For each agent and each time point, three wells were
seeded to yield data in triplicate. Cell survival was deter-
mined by counting the number of trypan blue-negative
cells. Briefly, cells were harvested by washing the culture
flasks with phosphate buffered saline (Hyclone, Logan,
UT) before addition of 0.5 ml trypsin (Cellgro, Hendon,
VA) and incubation at 37°C for 10 min. An equal volume
of Dulbecco's Eagle Modified Medium was then added,
and the cells were kept at room temperature during trypan
blue addition and counting. A 25 µl aliquot from the sus-
pended cells was taken and incubated with an equal vol-
ume of trypan blue for 1 min prior to counting in the
hemocytometer. Viable cells (trypan blue negative) were
counted immediately after the treatment, time 0 h, at 8 h
and 24 h after treatment. Percentage of viable cells is rela-
tive to 100% at time 0 h in untreated controls.
Cloning of HO-1 cDNA
In parallel studies, the full-length mouse cDNA was
obtained and subcloned downstream of a tetracycline-
responsive promoter. Briefly, 500 ng of total RNA from
NO-treated NIH3T3 cells was used in a first strand synthe-
sis reaction, using commercially available reagents (Invit-
rogen; Carlsbad, CA). One tenth of this reaction was used
as a template in a polymerase chain reaction with primers
m3 (5'-ccgggatccacggtctccagtcgc-3') and m4 (5'-acgcgtc-
gacgttagataatgcc-3'). Amplified mHO-1 was digested with
Sal1-BamH1 and subcloned into these sites into the
pTREA- vector. Plasmid pTREA- is a derivative of commer-
cially available pTRE (Clontech; Palo Alto, CA), in which
the BGH polyadenylation signal has been removed by
Hpa1-BsaA1 digestion and re-ligation.
RNA isolation and analysis
Total RNA was extracted from the frozen samples using a
commercially available kit, according to the manufac-
turer's instructions (RNAeasy; Qiagen, Valencia, CA). RNA
concentrations were measured by UV spectroscopy at 260
nm. For analysis, 5 µg of total RNA samples were electro-
phoresed on denaturing agarose gels, and the separated
RNA was transferred to a Nytran nylon membrane by ver-
tical capillary transfer. Membranes were UV-crosslinked
and hybridized at 68°C in Quickhybe solution (Strata-
gene; La Jolla, CA) to a radiolabelled probe. To probe for
the full-length mHO-1 cDNA, a 1.6-kb BamH1-Sal1 frag-
ment from plasmid pTREA-mHO was used. For the dead-
enylation assays, we used a probe corresponding to the 3'
end of the mHO-1 cDNA. This probe corresponds to the
466-bp of 3' end of the mouse HO-1 cDNA, encompassed
between the HindIII sites at position 1098 of the cDNA
and the multiple cloning site of pTREA-mHO vector. After
stripping, the blots were reprobed with a 1.3-kb Pst1 frag-
ment from the human glycerlaldehyde-3-phosphate
dehydrogenase (GAPDH) to control for differences in
loading. These probes were labeled by the random prim-
ing method, using a commercially available system, asBMC Molecular Biology 2007, 8:116 http://www.biomedcentral.com/1471-2199/8/116
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described by the manufacturer (Invitrogen; Carlsbad, CA).
After probing, the membrane was subjected to two low-
stringency washes and a high-stringency wash as sug-
gested by the manufacturer of the hybridization solution.
All blots were quantified with a Storm840 Phosphorim-
ager (Applied Biosystems; Piscataway, NJ).
HO-1 mRNA half-life determination
After subtraction of background signals (due to probing
for the loading control, GAPDH) present at 4 h in the con-
trol samples, the HO-1 mRNA decay constants were calcu-
lated by applying a linear least squares fit to the following
equation, which is a linearized version of the expected
mRNA decay function:
ln(Nt) = ln(N0) - λt
where ln indicates the natural logarithm; Nt is the amount
of HO-1 mRNA at a given time of actinomycin treatment;
N0 is the amount of HO-1 mRNA at time zero; λ is the
decay rate per unit of time; and t indicates the actinomy-
cin incubation time. The calculated slope from the linear
least squares fit is the decay rate, which can be used to
compute the half-lives by calculating:
t1/2 = ln2/λ
The calculated decay rate was also used to plot the fitted
decay rate lines, shown in Figures 1B, 1D, 2B, 3B, 4C, 5C,
6C. The statistical analysis of the HO-1 mRNA half-lives
reflects the difference in the slopes of the decay lines,
rather than comparing the values at each time point.
Primer extension assays
NIH3T3 cells were treated as controls (incubated with
conditioned medium) or treated with 0.5 mM SPER/NO
for 1 h prior to RNA extraction. Primer extension was
done using 10 µg of total RNA as template and primer m6
(5'-gggcatgctgtcgggctgtgg-3'), complementary to the
mouse HO-1 cDNA sequence from positions 137 to 158
nt. Primer m6 was 5' end-labeled using T4-kinase, in a 15
µl reaction containing 3.8 pmol of primer, 3.3 pmol γ-P32
ATP and 2 U T4-kinase (New England Biolabs; Beverly,
MA). The reaction mixture was incubated for 1 h at 37°C
before gel filtration purification. Primer extension reac-
tions were conducted using avian myoblastosis virus
(AMV) – reverse transcriptase as described by the manu-
facturer (Promega; Madison, WI). Reaction products were
separated by electrophoresis in a 5% polyacrylamide
sequencing gel.
Deadenylation assays
Deadenylation assays were conducted as described by
Shyu et al. [28]. Briefly, an oligo-directed cleavage reac-
tion was set up by adding 1 mM EDTA, and 37.5 mM
primer m10 (5'ccacattggacagagttcacagc-3') to 15–25 µg
samples of total RNA from each time point in a 10 µl vol-
ume. After an initial 65°C denaturation, annealing of
primer m10 to its complementary sequence in HO-1
mRNA was done by slowly cooling the sample to room
temperature for 15 min. RNA in this oligo-RNA hybrid
was cleavaged by addition of 2.8 U of RNAse H, 20 U
RNAsin and 10 U of SuperaseIn in 20 µl of a reaction
buffer containing: 20 mM Hepes pH 7.6, 5 mM MgCl2, 30
mM KCl and 0.5 mM dithiothriol. Reactions were incu-
bated 40 min at 37°C. RNA was precipitated by adding 20
µl NH4OAc, 112 µl ethanol and 25 µg glycogen as carrier
and incubating this reaction at -20°C overnight. RNA was
washed twice with 75% ethanol, and cleavage products
were separated by denaturing electrophoresis in a 2.56%
agarose gel. After electrophoresis, RNA was transferred to
a Nytran nylon membrane and analyzed by northern blot-
ting, as described before. A fraction of the total RNA was
left undigested and used to measure the half-life of HO-1
mRNA, as described above. To determine the deadenyla-
tion rate, the length of the poly(A) tail attached to the
3'end fragment of HO-1 mRNA was estimated by compar-
ison against size markers, including a fully deadenylated
HO-1 fragment, made by RNase H and oligo(dT). In this
analysis we considered the upper bound of the mRNA as
the longest poly(A) tails in each time point, and used it for
quantification. The upper boundary was determined by
plotting the distribution of the hybridization signal for
each 3'end product in a Storm840 Phosphorimager
(Applied Biosystems; Piscataway, NJ), and by marking the
area under the curve at a position in which 95–98% of the
signal remained below the mark.
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NMD Nonsense-mediated decay
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